Get started
Author

Harmut Goldschmidt

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma
2015 · Sergio Giralt, Laurent Garderet, et al. · Transplantation and Cellular Therapy · 165
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)
2001 · B Björkstrand, H Svensson, et al. · Bone Marrow Transplantation · 97
Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation
2002 · M. Hensel, G. Egerer, et al. · Annals of Oncology · 96
PDF
Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation
2010 · A C Sprynski, D Hose, et al. · Leukemia · 90
Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial
2015 · M. Merz, H. Salwender, et al. · Haematologica · 73
PDF
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping
2008 · David C. Johnson, Sophie Corthals, et al. · Blood · 68
PDF
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)
2007 · M Hundemer, U Klein, et al. · Bone Marrow Transplantation · 66
Frequency, Characteristics, and Reversibility of Peripheral Neuropathy (PN) in the APEX Trial.
2005 · J.F. San Miguel, P. Richardson, et al. · Blood · 48
Recombinant human granulocyte and granulocyte–macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells
1998 · S Hohaus, H Martin, et al. · Bone Marrow Transplantation · 47
Performance assessment and benchmarking of autologous peripheral blood stem cell collection with two different apheresis devices
2016 · P. Wuchter, M. Hundemer, et al. · Transfusion Medicine · 24
Input of DNA Microarrays to Identify Novel Mechanisms in Multiple Myeloma Biology and Therapeutic Applications
2007 · Karène Mahtouk, Dirk Hose, et al. · Clinical Cancer Research · 22
Transient complete remission of metastasized Merkel cell carcinoma by high-dose polychemotherapy and autologous peripheral blood stem cell transplantation
2000 · V. Waldmann, H. Goldschmidt, et al. · British Journal of Dermatology · 21
Natural History of Multiple Myeloma Relapsing After Therapy with IMiDs and Bortezomib: A Multicenter International Myeloma Working Group Study.
2009 · Shaji Kumar, Joan Blade, et al. · Blood · 19
Dynamische MRT des Knochenmarks zum Monitoring des Multiplen Myeloms unter Thalidomid-Monotherapie oder Kombination mit CED-Chemotherapie
2004 · K Wasser, T Moehler, et al. · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 17
Pomalidomide + Low-Dose Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma and Renal Impairment: Analysis of Patients from the Phase 3b Stratus Trial (MM-010)
2014 · Katja Weisel, Meletios A. Dimopoulos, et al. · Blood · 15
Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial
2016 · M. Merz, H. Salwender, et al. · Haematologica · 14
Successful Treatment of Bronchiolitis obliterans Organizing Pneumonia with Low-Dose Methotrexate in a Patient with Hodgkin’s Disease
2001 · G. Egerer, M. Witzens, et al. · Oncology · 12
Impact of FISH and Cytogenetics On Overall and Event Free Survival in Myeloma: An IMWG Analysis of 9,897 Patients.
2009 · Herve Avet-Loiseau, Brian G M Durie, et al. · Blood · 9
Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasone
2001 · Egerer G., Hegenbart U., et al. · Supportive Care in Cancer · 7
Autologous blood progenitor cell transplantation in relapsed Hodgkin's disease--the role of haematopoietic growth factors.
1993 · R Haas, S Hohaus, et al. · PubMed · 7
Positron emission tomography (PET) for diagnosis and therapy management of malignant lymphomas
1997 · Antonia Dimitrakopoulou-Strauss, L. G. Strauss, et al. · Der Radiologe · 6
POSTER: MM-161 Talquetamab + Daratumumab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Updated TRIMM-2 Results
2023 · Bhagirathbhai Dholaria, Katja Weisel, et al. · Clinical Lymphoma Myeloma & Leukemia · 2
P936: Time to Response, Duration of Response, and Patient-reported Outcomes With Daratumumab Plus Rd Vs Rd Alone in Transplant-ineligible Patients With Ndmm: Subgroup Analysis of the Phase 3 Maia Study
2022 · T. Facon, S. K. Kumar, et al. · HemaSphere · 2
P959: Ciltacabtagene Autoleucel in Lenalidomide-refractory Patients With Progressive Multiple Myeloma After 1-3 Prior Lines of Therapy: Cartitude-2 Biological Correlative Analyses and Updated Clinical Data
2022 · J. Hillengass, A. D. Cohen, et al. · HemaSphere · 2
A new therapeutic strategy with methotrexate-albumin in multiple myeloma?
2000 · H. Lannert, Madeleine Salzer, et al. · 2
Works count: 70
Citation count: 940
H-index: 15
I10-index: 17
Year
Topic
Type